Sopharma Trading AD Statistics

Total Valuation

Sopharma Trading AD has a market cap or net worth of BGN 198.74 million. The enterprise value is 490.60 million.

Market Cap	198.74M
Enterprise Value	490.60M

Important Dates

The next estimated earnings date is Friday, January 24, 2025.

Earnings Date	Jan 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Sopharma Trading AD has 34.27 million shares outstanding. The number of shares has increased by 0.66% in one year.

Current Share Class	n/a
Shares Outstanding	34.27M
Shares Change (YoY)	+0.66%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	1.26%
Float	4.20M

Valuation Ratios

The trailing PE ratio is 5.23.

PE Ratio	5.23
Forward PE	n/a
PS Ratio	0.11
PB Ratio	1.28
P/TBV Ratio	2.11
P/FCF Ratio	4.31
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.00, with an EV/FCF ratio of 10.63.

EV / Earnings	12.86
EV / Sales	0.26
EV / EBITDA	5.00
EV / EBIT	9.21
EV / FCF	10.63

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 1.92.

Current Ratio	1.08
Quick Ratio	0.58
Debt / Equity	1.92
Debt / EBITDA	3.08
Debt / FCF	6.55
Interest Coverage	5.58

Financial Efficiency

Return on equity (ROE) is 27.33% and return on invested capital (ROIC) is 7.85%.

Return on Equity (ROE)	27.33%
Return on Assets (ROA)	4.68%
Return on Capital (ROIC)	7.85%
Revenue Per Employee	564,318
Profits Per Employee	11,594
Employee Count	2,616
Asset Turnover	2.61
Inventory Turnover	6.66

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.13% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-4.13%
50-Day Moving Average	5.80
200-Day Moving Average	5.82
Relative Strength Index (RSI)	48.64
Average Volume (20 Days)	2,569

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sopharma Trading AD had revenue of BGN 1.86 billion and earned 38.15 million in profits. Earnings per share was 1.11.

Revenue	1.86B
Gross Profit	230.14M
Operating Income	53.36M
Pretax Income	41.26M
Net Income	38.15M
EBITDA	82.09M
EBIT	53.36M
Earnings Per Share (EPS)	1.11

Full Income Statement

Balance Sheet

The company has 13.24 million in cash and 302.30 million in debt, giving a net cash position of -289.05 million or -8.44 per share.

Cash & Cash Equivalents	13.24M
Total Debt	302.30M
Net Cash	-289.05M
Net Cash Per Share	-8.44
Equity (Book Value)	157.58M
Book Value Per Share	4.52
Working Capital	46.48M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 59.78 million and capital expenditures -13.64 million, giving a free cash flow of 46.14 million.

Operating Cash Flow	59.78M
Capital Expenditures	-13.64M
Free Cash Flow	46.14M
FCF Per Share	1.35

Full Cash Flow Statement

Margins

Gross margin is 12.40%, with operating and profit margins of 2.87% and 2.05%.

Gross Margin	12.40%
Operating Margin	2.87%
Pretax Margin	2.22%
Profit Margin	2.05%
EBITDA Margin	4.42%
EBIT Margin	2.87%
FCF Margin	2.49%

Dividends & Yields

Sopharma Trading AD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	0.07%
Buyback Yield	-0.66%
Shareholder Yield	-0.66%
Earnings Yield	19.12%
FCF Yield	23.21%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sopharma Trading AD has an Altman Z-Score of 3.02.

Altman Z-Score	3.02
Piotroski F-Score	n/a